During the past decade, Klinikum Garmisch-Partenkirchen Gmbh conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Garmisch-Partenkirchen Gmbh" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "Deutsches Herzzentrum Muenchen" with 3 trials sponsored, "Celgene" with 2 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored and "DePuy International" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Garmisch-Partenkirchen Gmbh" #1 collaborator was "Technical University of Munich" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Garmisch-Partenkirchen Gmbh" are "Chronic Lymphocytic Leukemia" (5 trials), "Coronary Artery Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials), "Leukemia" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Klinikum Garmisch-Partenkirchen Gmbh" in a lesser frequency.

Most popular intervention types in "Klinikum Garmisch-Partenkirchen Gmbh" are "Drug" (17 trials), "Biological" (6 trials), "Device" (4 trials), "Other" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (4 trials), "cyclophosphamide" (4 trials), "Rituximab" (3 trials), "radiation therapy" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Garmisch-Partenkirchen Gmbh" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Garmisch-Partenkirchen Gmbh". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Klinikum Garmisch-Partenkirchen Gmbh, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Garmisch-Partenkirchen Gmbh, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".